ARTICLE | Clinical News
Natesto regulatory update
June 2, 2014 7:00 AM UTC
FDA approved an NDA from Trimel for Natesto to treat testosterone deficiency. The company said it has not yet established a launch date or pricing for the product. In January, FDA extended by 3 months...